FibroGen Shares Outstanding 2013-2020 | FGEN

FibroGen shares outstanding from 2013 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
FibroGen Annual Shares Outstanding
(Millions of Shares)
2020 90
2019 87
2018 84
2017 73
2016 63
2015 60
2014 19
2013 13
2012 13
FibroGen Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 90
2020-09-30 94
2020-06-30 89
2020-03-31 88
2019-12-31 87
2019-09-30 87
2019-06-30 92
2019-03-31 86
2018-12-31 84
2018-09-30 85
2018-06-30 84
2018-03-31 83
2017-12-31 73
2017-09-30 76
2017-06-30 70
2017-03-31 64
2016-12-31 63
2016-09-30 63
2016-06-30 69
2016-03-31 62
2015-12-31 60
2015-09-30 61
2015-06-30 69
2015-03-31 59
2014-12-31 35
2014-09-30 14
2014-06-30 37
2014-03-31 13
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.806B $0.176B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.646B 42.46
Takeda Pharmaceutical (TAK) Japan $53.647B 9.83
Astellas Pharma (ALPMY) Japan $28.188B 17.40
Eisai (ESALY) Japan $19.710B 21.86
Catalent (CTLT) United States $18.562B 49.12
Grifols, S.A (GRFS) Spain $12.273B 14.28
Jazz Pharmaceuticals (JAZZ) Ireland $9.199B 15.36
United Therapeutics (UTHR) United States $8.878B 17.24
Neurocrine Biosciences (NBIX) United States $8.789B 20.25
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.479B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.635B 0.00
Evotec AG (EVTCY) Germany $6.555B 442.61
Orion OYJ (ORINY) Finland $5.789B 20.11
Ionis Pharmaceuticals (IONS) United States $5.788B 0.00
Sage Therapeutics (SAGE) United States $4.200B 0.00
Hypermarcas (HYPMY) Brazil $3.984B 15.73
Turning Point Therapeutics (TPTX) United States $3.664B 0.00
Nektar Therapeutics (NKTR) United States $3.407B 0.00
PTC Therapeutics (PTCT) United States $3.327B 0.00
ChemoCentryx (CCXI) United States $3.290B 0.00
Tilray (TLRY) Canada $3.147B 0.00
Cronos Group (CRON) Canada $3.030B 0.00
Pacira BioSciences (PCRX) United States $2.994B 50.56
Relay Therapeutics (RLAY) United States $2.890B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.770B 17.15
Revolution Medicines (RVMD) United States $2.758B 0.00
Organogenesis Holdings (ORGO) United States $2.700B 162.31
Corcept Therapeutics (CORT) United States $2.614B 26.21
Xencor (XNCR) United States $2.330B 0.00
USANA Health Sciences (USNA) United States $2.069B 17.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.727B 11.08
BioCryst Pharmaceuticals (BCRX) United States $1.719B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.660B 13.05
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.630B 0.00
Sundial Growers (SNDL) Canada $1.627B 0.00
AlloVir (ALVR) United States $1.541B 0.00
Heron Therapeutics (HRTX) United States $1.523B 0.00
ImmunoGen (IMGN) United States $1.452B 0.00
Endo (ENDP) Ireland $1.408B 2.13
Aclaris Therapeutics (ACRS) United States $1.371B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.342B 0.00
Indivior (INVVY) United States $1.333B 0.00
Translate Bio (TBIO) United States $1.310B 0.00
Ocular Therapeutix (OCUL) United States $1.209B 0.00
Zogenix (ZGNX) United States $1.064B 0.00
Trillium Therapeutics (TRIL) Canada $1.038B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.997B 0.00
4D Molecular Therapeutics (FDMT) $0.954B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.886B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Bioventus (BVS) United States $0.814B 0.00
Collegium Pharmaceutical (COLL) United States $0.807B 30.15
Karyopharm Therapeutics (KPTI) United States $0.758B 0.00
Esperion Therapeutics (ESPR) United States $0.732B 0.00
Ardelyx (ARDX) United States $0.711B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Rafael Holdings (RFL) United States $0.672B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.667B 0.00
VAXART, INC (VXRT) United States $0.650B 0.00
Harpoon Therapeutics (HARP) United States $0.644B 0.00
KalVista Pharmaceuticals (KALV) United States $0.636B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.614B 0.00
Chinook Therapeutics (KDNY) United States $0.589B 0.00
Sigilon Therapeutics (SGTX) $0.587B 0.00
Siga Technologies (SIGA) United States $0.540B 9.01
Nanobiotix S.A (NBTX) France $0.539B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.518B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.499B 0.00
TherapeuticsMD (TXMD) United States $0.495B 0.00
Altimmune (ALT) United States $0.471B 0.00
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.456B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.455B 10.68
Foghorn Therapeutics (FHTX) United States $0.450B 0.00
AVITA Medical (RCEL) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.446B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Jounce Therapeutics (JNCE) United States $0.420B 0.00
PROFOUND MEDICL (PROF) Canada $0.415B 0.00
MEI Pharma (MEIP) United States $0.399B 0.00
DURECT (DRRX) United States $0.398B 0.00
Nature's Sunshine Products (NATR) United States $0.387B 18.44
Acutus Medical (AFIB) United States $0.370B 0.00
Innate Pharma SA (IPHYF) France $0.347B 0.00
Redhill Biopharma (RDHL) Israel $0.332B 0.00
Oncternal Therapeutics (ONCT) United States $0.317B 0.00
Clever Leaves Holdings (CLVR) United States $0.311B 0.00
VYNE Therapeutics (VYNE) United States $0.289B 0.00
Infinity Pharmaceuticals (INFI) United States $0.269B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Taiwan Liposome (TLC) Taiwan $0.250B 0.00
Alpine Immune Sciences (ALPN) United States $0.250B 0.00
KemPharm (KMPH) United States $0.245B 0.00
Xeris Pharmaceuticals (XERS) United States $0.237B 0.00
Inotiv (NOTV) United States $0.233B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Iterum Therapeutics (ITRM) Ireland $0.224B 0.00
Jaguar Animal Health (JAGX) United States $0.220B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.218B 0.00
Progenity (PROG) United States $0.212B 0.00
Sierra Oncology (SRRA) Canada $0.210B 0.00
Novan (NOVN) United States $0.202B 0.00
Lannett Co Inc (LCI) United States $0.201B 6.75
Oasmia Pharmaceutical AB (OASMY) Sweden $0.200B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.198B 0.00
OptiNose (OPTN) United States $0.187B 0.00
CTI BioPharma (CTIC) United States $0.185B 0.00
IMV INC (IMV) Canada $0.185B 0.00
Heat Biologics (HTBX) United States $0.170B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.166B 0.00
Adherex Technologies (FENC) United States $0.164B 0.00
Calithera Biosciences (CALA) United States $0.159B 0.00
SCYNEXIS (SCYX) United States $0.159B 0.00
Onconova Therapeutics (ONTX) United States $0.159B 0.00
Vivos Therapeutics (VVOS) $0.158B 0.00
Qilian Holding Group (QLI) China $0.156B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Concert Pharmaceuticals (CNCE) United States $0.149B 0.00
IsoRay (ISR) United States $0.147B 0.00
MediWound (MDWD) Israel $0.139B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
Aziyo Biologics (AZYO) United States $0.134B 0.00
Nutriband (NTRB) United States $0.133B 0.00
Lipocine (LPCN) United States $0.131B 0.00
GlycoMimetics (GLYC) United States $0.130B 0.00
Genocea Biosciences (GNCA) United States $0.123B 0.00
PolarityTE (PTE) United States $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.110B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Natural Alternatives (NAII) United States $0.107B 29.14
Otonomy (OTIC) United States $0.105B 0.00
Minerva Neurosciences (NERV) United States $0.103B 40.33
AIM ImmunoTech (AIM) United States $0.103B 0.00
Savara (SVRA) United States $0.098B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.095B 0.00
Recro Pharma (REPH) United States $0.091B 0.00
Assertio Holdings (ASRT) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Regulus Therapeutics (RGLS) United States $0.086B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
ProPhase Labs (PRPH) United States $0.077B 0.00
Baudax Bio (BXRX) United States $0.077B 0.00
India Globalization Capital (IGC) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.069B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Brickell Biotech (BBI) United States $0.061B 0.00
AgeX Therapeutics (AGE) United States $0.060B 0.00
Biomerica (BMRA) United States $0.058B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.057B 0.00
Inhibikase Therapeutics (IKT) United States $0.055B 0.00
HANCOCK JAFFE (HJLI) United States $0.054B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 62.40
Viracta Therapeutics (VIRX) United States $0.041B 0.00
Mannatech (MTEX) United States $0.040B 7.12
Can-Fite Biopharma (CANF) Israel $0.039B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.034B 0.00
4D Pharma (LBPS) United Kingdom $0.033B 0.00
RXi Pharmaceuticals (PHIO) United States $0.032B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
JanOne (JAN) United States $0.021B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 15.75
Xenetic Biosciences (XBIO) United States $0.019B 0.00
SHINECO INC (TYHT) China $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00